Hjem › Rhabdomyosarkom › New York
Rhabdomyosarkom kliniske forsøg i New York
4 studier for Rhabdomyosarkom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Albany Medical Center, Albany
- University of Rochester, Rochester
- Montefiore Medical Center - Moses Campus, The Bronx
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT07466316Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- New York Medical College, Valhalla
RekruttererFase 1
Alder 1 til 30 · Alle køn · Opdateret 15. apr. 2026 · NCT04308330Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
RekruttererFase 2
Alder 1 til 50 · Alle køn · Opdateret 13. mar. 2026 · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.